William Hurbert Shaw
Physician at Hibiscus Dr, Miami, FL
License number
Colorado 32525
Issued Date
Apr 15, 1993
Renew Date
Jun 1, 2001
Expiration Date
May 31, 2003
Type
Physician
Address
Address
205 N Hibiscus Dr, Miami, FL 33139
Professional information
Licensed Florida Agent Life, Health, Fixed Annuities
Position:
Licensed Florida Agent at Agent
Location:
Miami/Fort Lauderdale Area
Industry:
Financial Services
Work:
Agent
since Jan 2010
-
Licensed Florida Agent
Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon
US Patent:
2007017, Aug 2, 2007
Filed:
Apr 17, 2007
Appl. No.:
11/736137
Inventors:
Luis Davila - Pleasanton CA, US
David Lentz - Weston FL, US
Gerard Llanos - Stewartsville NJ, US
Jorge Mendez - Miami FL, US
Pallassana Narayanan - Belle Mead NJ, US
Alan Pelton - Fremont CA, US
Mark Roller - North Brunswick NJ, US
Karl Scheidt - Pembroke Pines FL, US
Angelo Scopelianos - Whitehouse Station NJ, US
William Shaw - Miami FL, US
James Silver - Redwood City CA, US
John Spaltro - Asbury NJ, US
Christine Trepanier - Fremont CA, US
David Wilson - Branchburg NJ, US
David Lentz - Weston FL, US
Gerard Llanos - Stewartsville NJ, US
Jorge Mendez - Miami FL, US
Pallassana Narayanan - Belle Mead NJ, US
Alan Pelton - Fremont CA, US
Mark Roller - North Brunswick NJ, US
Karl Scheidt - Pembroke Pines FL, US
Angelo Scopelianos - Whitehouse Station NJ, US
William Shaw - Miami FL, US
James Silver - Redwood City CA, US
John Spaltro - Asbury NJ, US
Christine Trepanier - Fremont CA, US
David Wilson - Branchburg NJ, US
International Classification:
A61F 2/90
US Classification:
623001420, 427002240
Abstract:
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.
Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon
US Patent:
2007017, Aug 2, 2007
Filed:
Apr 17, 2007
Appl. No.:
11/736271
Inventors:
Luis Davila - Pleasanton CA, US
David Lentz - Weston FL, US
Gerard Llanos - Stewartsville NJ, US
Jorge Mendez - Miami FL, US
Pallassana Narayanan - Belle Mead NJ, US
Alan Pelton - Fremont CA, US
Mark Roller - North Brunswick NJ, US
Karl Scheidt - Pembroke Pines FL, US
Angelo Scopelianos - Whitehouse Station NJ, US
William Shaw - Miami FL, US
James Silver - Redwood City CA, US
John Spaltro - Asbury NJ, US
Christine Trepanier - Union City CA, US
David Wilson - Branchburg NJ, US
David Lentz - Weston FL, US
Gerard Llanos - Stewartsville NJ, US
Jorge Mendez - Miami FL, US
Pallassana Narayanan - Belle Mead NJ, US
Alan Pelton - Fremont CA, US
Mark Roller - North Brunswick NJ, US
Karl Scheidt - Pembroke Pines FL, US
Angelo Scopelianos - Whitehouse Station NJ, US
William Shaw - Miami FL, US
James Silver - Redwood City CA, US
John Spaltro - Asbury NJ, US
Christine Trepanier - Union City CA, US
David Wilson - Branchburg NJ, US
International Classification:
A61F 2/90, B05D 3/00, A61L 33/00
US Classification:
623001420, 427002240
Abstract:
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.
Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon
US Patent:
2002011, Aug 15, 2002
Filed:
Sep 25, 2001
Appl. No.:
09/962496
Inventors:
Luis Davila - Pleasanton CA, US
David Lentz - Weston FL, US
Gerard Llanos - Stewartsville NJ, US
Jorge Mendez - Miami FL, US
Pallassana Narayanan - Belle Mead NJ, US
Alan Pelton - Fremont CA, US
Mark Roller - North Brunswick NJ, US
Karl Scheidt - Pembroke Pines FL, US
Angelo Scopelianos - Whitehouse Station NJ, US
William Shaw - Miami FL, US
James Silver - Redwood City CA, US
John Spaltro - Asbury NJ, US
Christine Trepanier - Fremont CA, US
David Wilson - Ft. Lauderdale FL, US
David Lentz - Weston FL, US
Gerard Llanos - Stewartsville NJ, US
Jorge Mendez - Miami FL, US
Pallassana Narayanan - Belle Mead NJ, US
Alan Pelton - Fremont CA, US
Mark Roller - North Brunswick NJ, US
Karl Scheidt - Pembroke Pines FL, US
Angelo Scopelianos - Whitehouse Station NJ, US
William Shaw - Miami FL, US
James Silver - Redwood City CA, US
John Spaltro - Asbury NJ, US
Christine Trepanier - Fremont CA, US
David Wilson - Ft. Lauderdale FL, US
International Classification:
A61M005/32, A61M025/00
US Classification:
604/265000, 623/001150, 623/001420
Abstract:
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.
Medical Devices, Drug Coatings And Methods Of Maintaining The Drug Coatings Thereon
US Patent:
2006022, Oct 5, 2006
Filed:
May 19, 2006
Appl. No.:
11/437572
Inventors:
Luis Davila - Pleasanton CA, US
David Lentz - Weston FL, US
Gerard Llanos - Stewartsville NJ, US
Jorge Mendez - Miami FL, US
Pallassana Narayanan - Belle Mead NJ, US
Alan Pelton - Fremont CA, US
Mark Roller - North Brunswick NJ, US
Karl Scheidt - Pembroke Pines FL, US
Angelo Scopelianos - Whitehouse Station NJ, US
William Shaw - Miami FL, US
James Silver - Palo Alto CA, US
John Spaltro - Asbury NJ, US
Christine Trepanier - Union City CA, US
David Wilson - Ft. Lauderdale FL, US
David Lentz - Weston FL, US
Gerard Llanos - Stewartsville NJ, US
Jorge Mendez - Miami FL, US
Pallassana Narayanan - Belle Mead NJ, US
Alan Pelton - Fremont CA, US
Mark Roller - North Brunswick NJ, US
Karl Scheidt - Pembroke Pines FL, US
Angelo Scopelianos - Whitehouse Station NJ, US
William Shaw - Miami FL, US
James Silver - Palo Alto CA, US
John Spaltro - Asbury NJ, US
Christine Trepanier - Union City CA, US
David Wilson - Ft. Lauderdale FL, US
Assignee:
Cordis Corporation - Miami Lakes FL
International Classification:
B05D 3/00, A61L 33/00
US Classification:
427002240
Abstract:
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.
Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon
US Patent:
2004010, May 27, 2004
Filed:
Aug 7, 2003
Appl. No.:
10/636435
Inventors:
Luis Davila - Coral Springs FL, US
David Lentz - Weston FL, US
Gerard Llanos - Stewartsville NJ, US
Jorge Mendez - Miami FL, US
Pallassana Narayanan - Belle Mead NJ, US
Alan Pelton - Fremont CA, US
Mark Roller - North Brunswick NJ, US
Karl Scheidt - Pembroke Pines FL, US
Angelo Scopelianos - Whitehouse Station NJ, US
William Shaw - Miami FL, US
James Silver - Palo Alto CA, US
John Spaltro - Asbury NJ, US
Christine Trepanier - Union City CA, US
David Wilson - Branchburg NJ, US
David Lentz - Weston FL, US
Gerard Llanos - Stewartsville NJ, US
Jorge Mendez - Miami FL, US
Pallassana Narayanan - Belle Mead NJ, US
Alan Pelton - Fremont CA, US
Mark Roller - North Brunswick NJ, US
Karl Scheidt - Pembroke Pines FL, US
Angelo Scopelianos - Whitehouse Station NJ, US
William Shaw - Miami FL, US
James Silver - Palo Alto CA, US
John Spaltro - Asbury NJ, US
Christine Trepanier - Union City CA, US
David Wilson - Branchburg NJ, US
International Classification:
A61M031/00
US Classification:
604/500000
Abstract:
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.
Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon
US Patent:
2007017, Aug 2, 2007
Filed:
Apr 17, 2007
Appl. No.:
11/736043
Inventors:
Luis Davila - Coral Springs FL, US
David Lentz - Weston FL, US
Gerard Llanos - Stewartsville NJ, US
Jorge Mendez - Miami FL, US
Pallassana Narayanan - Bell Mead NJ, US
Alan Pelton - Fremont CA, US
Mark Roller - North Brunswick NJ, US
Karl Scheidt - Pembroke Pines FL, US
Angelo Scopelianos - Whitehouse Station NJ, US
William Shaw - Miami FL, US
James Silver - Palo Alto CA, US
John Spaltro - Asbury NJ, US
Christine Trepanier - Union City CA, US
David Wilson - Branchburg NJ, US
David Lentz - Weston FL, US
Gerard Llanos - Stewartsville NJ, US
Jorge Mendez - Miami FL, US
Pallassana Narayanan - Bell Mead NJ, US
Alan Pelton - Fremont CA, US
Mark Roller - North Brunswick NJ, US
Karl Scheidt - Pembroke Pines FL, US
Angelo Scopelianos - Whitehouse Station NJ, US
William Shaw - Miami FL, US
James Silver - Palo Alto CA, US
John Spaltro - Asbury NJ, US
Christine Trepanier - Union City CA, US
David Wilson - Branchburg NJ, US
International Classification:
A61F 2/90, A61L 33/00, B05D 3/00
US Classification:
623001420, 427002100
Abstract:
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.
Radiopacity Intraluminal Medical Device
US Patent:
2002014, Oct 3, 2002
Filed:
Jun 19, 2001
Appl. No.:
09/884729
Inventors:
Luis Davila - Pleasanton CA, US
Jorge Mendez - Miami FL, US
Alan Pelton - Fremont CA, US
Karl Scheidt - Pembroke Pines FL, US
William Shaw - Miami FL, US
James Silver - Redwood City CA, US
Christine Trepanier - Fremont CA, US
David Wilson - Ft. Lauderdale FL, US
Jorge Mendez - Miami FL, US
Alan Pelton - Fremont CA, US
Karl Scheidt - Pembroke Pines FL, US
William Shaw - Miami FL, US
James Silver - Redwood City CA, US
Christine Trepanier - Fremont CA, US
David Wilson - Ft. Lauderdale FL, US
International Classification:
A61F002/06
US Classification:
623/001150, 623/001340
Abstract:
A stent or other intraluminal medical device having markers formed from housings integral with the stent and marker inserts having a higher radiopacity than the stent provides for more precise placement and post-procedural visualization in a vessel, by increasing the radiopacity of the stent under X-ray fluoroscopy. The housings are formed integral to the stent and the marker inserts are made from a material close in the galvanic series to the stent material and sized to substantially minimize the effect of galvanic corrosion.
Low Profile Improved Radiopacity Intraluminal Medical Device
US Patent:
2002019, Dec 19, 2002
Filed:
Apr 22, 2002
Appl. No.:
10/127191
Inventors:
Bennie Gladdish - Davie FL, US
Marco Nino - Miami FL, US
William Shaw - Miami FL, US
Durk Sijbolts - Fremont CA, US
Dennis Vaughan - Miami FL, US
Marco Nino - Miami FL, US
William Shaw - Miami FL, US
Durk Sijbolts - Fremont CA, US
Dennis Vaughan - Miami FL, US
International Classification:
A61F002/06
US Classification:
623/001150, 623/001340
Abstract:
A stent or other intraluminal medical device having markers formed from housings integral with the stent and marker inserts having a higher radiopacity than the stent provides for more precise placement and post-procedural visualization in a vessel, by increasing the radiopacity of the stent under X-ray fluoroscopy. The housings are formed integral to the stent and the marker inserts are made from a material close in the galvanic series to the stent material and sized to substantially minimize the effect of galvanic corrosion. The housings are also shaped to minimize their impact on the overall profile of the stent.